✦ LIBER ✦

TCT-440 Two-year Clinical Outcomes Of Primary Stenting Of Totally Occluded Native Coronary Arteries III (PRISON III): A Randomized Comparison Of Sirolimus-Eluting Stent Implantation With Zotarolimus-Eluting Stent Implantation For The Treatment Of Total Coronary Occlusions

✍ Scribed by Koen Teeuwen; Ben Van den Branden; Jacques Koolen; Jose Henriques; Jan Tijssen; Hans Kelder; René Van der Schaaf; Paul Vermeersch; Benno Rensing; Maarten j. Suttorp

Book ID: 119272515
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 148 KB
Volume: 60
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2012.08.471

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized comparison of sirolimus-elu

A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: Rationale and design of the PRImary Stenting of Occluded Native coronary arteries III (PRISON III) study

✍ Maarten J. Suttorp; Gerrit J. Laarman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Three-year clinical outcome after primar

Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: A randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study)

✍ Braim M. Rahel; Gerrit J. Laarman; Johannes C. Kelder; Juriën M. ten Berg; Maart 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Primary stenting of occluded native coro

Primary stenting of occluded native coronary arteries II—Rationale and design of the PRISON II study: A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of chronic total coronary occlusions

✍ Braim M. Rahel; Gert J. Laarman; Maarten J. Suttorp 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 70 KB

TCT-254: 18-month Clinical Outcome After

TCT-254: 18-month Clinical Outcome After Implantation Of Zotarolimus-eluting Versus Sirolimus-eluting Stents In Patients With Acute Coronary Syndrome - A Sort Out III Substudy

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

Comparison of Everolimus-Eluting and Pac

Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention: The SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials

✍ Dean J. Kereiakes; Krishnankutty Sudhir; James B. Hermiller; Paul C. Gordon; Joa 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 939 KB